SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. Forthright who wrote (2328)	7/1/1998 3:01:00 PM
From: Springer	Read Replies (3) of 5402

Mr F... I want to play along too...but I totally agree with FM and the others...this is a risky Biotech investment..in it's early stages. Valuation Models at this stage are almost pointless.. but it's fun to speculate... From what I understand... 1)15-20B worldwide. The AABB gave a exact number for the US market...and you could extrapolate that to get another guess...but I am lazy... 2) 75-95%. This is the only product that hasn't killed anybody yet. ;) besides real blood that is...again, a guess. Remeber that there are also other uses for it besides as a blood subsitute. 3) I think this is your "catch"....Don't know. Maybe 1-10 years ?? Depends. Hard to even speculate... AIDS is making the news again about Drug resistant strains. Maybe we'll find out that if you use this product and asprin you'll explode....Waiting for FTD approval....but hey, thus the risk...being in on the Viagra Stock 2 years ago would have been nice.... What are Your guesses.... Springer

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next